SLC7A11 and cancer: For example, Li et al. discovered that Nrf2/xCT pathway activation was associated with the resistance of cancer cells to cisplatin and demonstrated that erastin/sorafenib could induce ferroptosis in cisplatin-resistant non-small cell lung cancer cells, effectively enhancing the effect of chemotherapy (Li et al., 2020).